These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
555 related articles for article (PubMed ID: 23526406)
1. p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption. Nagai Y; Osawa K; Fukushima H; Tamura Y; Aoki K; Ohya K; Yasuda H; Hikiji H; Takahashi M; Seta Y; Seo S; Kurokawa M; Kato S; Honda H; Nakamura I; Maki K; Jimi E J Bone Miner Res; 2013 Dec; 28(12):2449-62. PubMed ID: 23526406 [TBL] [Abstract][Full Text] [Related]
2. Kif1c regulates osteoclastic bone resorption as a downstream molecule of p130Cas. Kobayakawa M; Matsubara T; Mizokami A; Hiura F; Takakura N; Kokabu S; Matsuda M; Yasuda H; Nakamura I; Takei Y; Honda H; Hosokawa R; Jimi E Cell Biochem Funct; 2020 Apr; 38(3):300-308. PubMed ID: 31887784 [TBL] [Abstract][Full Text] [Related]
3. The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts. Vives V; Laurin M; Cres G; Larrousse P; Morichaud Z; Noel D; Côté JF; Blangy A J Bone Miner Res; 2011 May; 26(5):1099-110. PubMed ID: 21542010 [TBL] [Abstract][Full Text] [Related]
4. Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling. Uehara S; Udagawa N; Mukai H; Ishihara A; Maeda K; Yamashita T; Murakami K; Nishita M; Nakamura T; Kato S; Minami Y; Takahashi N; Kobayashi Y Sci Signal; 2017 Aug; 10(494):. PubMed ID: 28851822 [TBL] [Abstract][Full Text] [Related]
5. The unique function of p130Cas in regulating the bone metabolism. Jimi E; Honda H; Nakamura I Pharmacol Ther; 2022 Feb; 230():107965. PubMed ID: 34391790 [TBL] [Abstract][Full Text] [Related]
6. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase. Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2. Duong LT; Nakamura I; Lakkakorpi PT; Lipfert L; Bett AJ; Rodan GA J Biol Chem; 2001 Mar; 276(10):7484-92. PubMed ID: 11102447 [TBL] [Abstract][Full Text] [Related]
9. p130Cas-dependent actin remodelling regulates myogenic differentiation. Kawauchi K; Tan WW; Araki K; Abu Bakar FB; Kim M; Fujita H; Hirata H; Sawada Y Biochem J; 2012 Aug; 445(3):323-32. PubMed ID: 22587391 [TBL] [Abstract][Full Text] [Related]
10. Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70. Garbe AI; Roscher A; Schüler C; Lutter AH; Glösmann M; Bernhardt R; Chopin M; Hempel U; Hofbauer LC; Rammelt S; Egerbacher M; Erben RG; Jessberger R J Bone Miner Res; 2012 Oct; 27(10):2085-96. PubMed ID: 22648978 [TBL] [Abstract][Full Text] [Related]
11. Distinct roles of p130Cas and c-Cbl in adhesion-induced or macrophage colony-stimulating factor-mediated signaling pathways in prefusion osteoclasts. Nakamura I; Rodan GA; Duong LT Endocrinology; 2003 Nov; 144(11):4739-41. PubMed ID: 12959979 [TBL] [Abstract][Full Text] [Related]
12. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity. Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185 [TBL] [Abstract][Full Text] [Related]
14. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts. Insogna K; Tanaka S; Neff L; Horne W; Levy J; Baron R Mol Reprod Dev; 1997 Jan; 46(1):104-8. PubMed ID: 8981371 [TBL] [Abstract][Full Text] [Related]
15. The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts. de Vries TJ; Mullender MG; van Duin MA; Semeins CM; James N; Green TP; Everts V; Klein-Nulend J Mol Cancer Res; 2009 Apr; 7(4):476-88. PubMed ID: 19372577 [TBL] [Abstract][Full Text] [Related]
16. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation. Duong LT; Rodan GA Front Biosci; 1998 Aug; 3():d757-68. PubMed ID: 9682033 [TBL] [Abstract][Full Text] [Related]
18. Methods to Investigate the Role of Rho GTPases in Osteoclast Function. Morel A; Blangy A; Vives V Methods Mol Biol; 2018; 1821():219-233. PubMed ID: 30062415 [TBL] [Abstract][Full Text] [Related]
19. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption. Su N; Li X; Tang Y; Yang J; Wen X; Guo J; Tang J; Du X; Chen L J Bone Miner Res; 2016 Sep; 31(9):1676-87. PubMed ID: 26990430 [TBL] [Abstract][Full Text] [Related]
20. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis. Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]